Teacher Retirement System of Texas’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$336K Sell
14,267
-1,713
-11% -$43.7K ﹤0.01% 1236
2025
Q4
$464K Sell
15,980
-10,277
-39% -$263K ﹤0.01% 1259
2025
Q3
$495K Sell
26,257
-2,517
-9% -$39.7K ﹤0.01% 1525
2025
Q2
$403K Buy
28,774
+422
+1% +$5.92K ﹤0.01% 1656
2025
Q1
$443K Sell
28,352
-2,864
-9% -$40.3K ﹤0.01% 1565
2024
Q4
$435K Buy
31,216
+5,087
+19% +$55.7K ﹤0.01% 1299
2024
Q3
$243K Buy
26,129
+3,402
+15% +$33.6K ﹤0.01% 1385
2024
Q2
$211K Buy
+22,727
New +$206K ﹤0.01% 1474
2023
Q4
Sell
-12,839
Closed -$68K 1788
2023
Q3
$68K Buy
12,839
+1,239
+11% +$10.5K ﹤0.01% 1844
2023
Q2
$111K Sell
11,600
-1,539
-12% -$17.1K ﹤0.01% 1851
2023
Q1
$145K Buy
13,139
+267
+2% +$3.86K ﹤0.01% 1922
2022
Q4
$191K Sell
12,872
-535
-4% -$9.35K ﹤0.01% 1867
2022
Q3
$256K Buy
+13,407
New +$304K ﹤0.01% 1821

Other funds holding ARQT

Teacher Retirement System of Texas's ARQT Position: Q1 2026 in Review

Teacher Retirement System of Texas reduced its Arcutis Biotherapeutics (ARQT) stake by 11% in Q1 2026, selling an estimated $43.7K and leaving 14,267 shares worth $336K. The position accounts for ﹤0.01% of the portfolio, ranked #1236.

Teacher Retirement System of Texas first reported a position in ARQT in Q3 2022 and has held it in 13 quarters since. The position peaked at $495K in Q3 2025. 269 funds tracked by Wall St. Rank hold ARQT as of Q1 2026.

  • Teacher Retirement System of Texas held 14,267 shares of Arcutis Biotherapeutics worth $336K as of Q1 2026.
  • Teacher Retirement System of Texas sold 1,713 Arcutis Biotherapeutics shares in Q1 2026, an estimated $43.7K.
  • Arcutis Biotherapeutics made up ﹤0.01% of Teacher Retirement System of Texas's portfolio in Q1 2026, its #1236 holding.
  • Teacher Retirement System of Texas first reported a position in Arcutis Biotherapeutics in Q3 2022 and has held it in 13 quarters since.
  • Teacher Retirement System of Texas's Arcutis Biotherapeutics position peaked at $495K in Q3 2025.
  • 269 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q1 2026.

Based on Teacher Retirement System of Texas's 13F filing for Q1 2026, filed 30 Apr 2026.